← Leaderboards
Timothy F. Burns
University Of Pittsburgh At Pittsburgh
$1,780,714
Attributed
$1,780,714
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $362.8K · FY2020–24$500K$375K$250K$125K$0
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$1,780,714 · 1
By mechanism
R01$1,780,714 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Andrew F. Stewart$27,613,128
- Jill M Siegfried$10,296,579
- Jennifer R Grandis$109,711,044
- Adolfo Garcia-Ocana$10,799,833
- Dong Moon Shin$11,702,631
Others in their field
Other Emerging Leaders on “Malignant Neoplasm Of Lung”
- Leonard Freedman · Leidos Biomedical Research, Inc.$50,919,602
- Greg Yothers · University Of Chicago$35,003,821
- Lynn Briscoe · Leidos Biomedical Research, Inc.$26,085,158
- Jeremy James Martinson · University Of Pittsburgh At Pittsburgh$15,658,268
- Rachana Agarwal · Leidos Biomedical Research, Inc.$15,241,462
- John Freymann · Leidos Biomedical Research, Inc.$14,011,208
Research focus
Malignant Neoplasm Of LungLung TumorigenesisApoptosisIn Vivo ModelIn VitroLinkDrug ResistanceApoptoticEfficacy TestingIn VivoClinicEpidermal Growth Factor Receptor Tyrosine Kinase InhibitorClinically SignificantBcl2l11 GeneErlotinibExperimental StudyFda ApprovedFunctional OutcomesGenerationsHarmineHgf GeneCell LineEpidermal Growth Factor ReceptorMediating
Grant awards (6)
Targeting the HGF-MET-TWIST1 pathway to overcome EGFR TKI resistance$203,351
R01 · FY2024 · CA · contact PI
Targeting the HGF-MET-TWIST1 pathway to overcome EGFR TKI resistance$142,177
R01 · FY2024 · CA · contact PI
Targeting the HGF-MET-TWIST1 pathway to overcome EGFR TKI resistance$356,438
R01 · FY2023 · CA · contact PI
Targeting the HGF-MET-TWIST1 pathway to overcome EGFR TKI resistance$362,760
R01 · FY2022 · CA · contact PI
Targeting the HGF-MET-TWIST1 pathway to overcome EGFR TKI resistance$357,994
R01 · FY2021 · CA · contact PI
Targeting the HGF-MET-TWIST1 pathway to overcome EGFR TKI resistance$357,994
R01 · FY2020 · CA · contact PI